The present study was performed to investigate the age-dependent changes in body composition and the possible role of growth hormone (GH), insulin-like growth factor (IGF)-I and IGF-binding protein-3 (IGFBP-3) in these changes in postmenopausal Japanese women. A total of 161 Japanese women aged 45-88 years (mean 62) were enrolled in the cross-sectional study. Body composition (bone mineral content (BMC), lean body mass (LBM) and fat) was measured by dual-energy X-ray absorptiometry, and the percentage of BMC, LBM and fat was calculated by dividing each absolute value of body composition by total body mass. Urinary GH concentration divided by creatinine in nocturnal urine samples collected just after waking was used as an index of endogenous GH secretion. Serum levels of IGF-I and IGFBP-3 were measured by RIA. Urinary GH levels as well as serum levels of IGF-I and IGFBP-3 declined with age. BMC, %BMC and LBM also declined with age, while fat mass and %fat did not obviously change with age. Urinary GH levels as well as serum levels of IGF-I and IGFBP-3 correlated positively with BMC, even if age was taken into account. On the other hand, urinary GH correlated negatively with fat and %fat. In contrast, serum levels of IGF-I and IGFBP-3 correlated positively with fat and %fat. LBM did not correlate with either urinary GH or serum IGFBP-3 levels but exhibited a weakly positive correlation with serum IGF-I level. The present study suggests that the GH-IGF-I-IGFBP-3 axis positively regulates bone mass, and that GH and IGF-I-IGFBP-3 inversely regulate fat mass, i.e. GH negatively and IGF-I-IGFBP-3 positively regulates it.
Introduction
It is well known that aging causes changes in body composition such as a decrease in bone mass (1) . Growth hormone (GH) secretion rate as well as serum levels of insulin-like growth factor (IGF)-I, an anabolic factor for bone (2) , and IGF-binding protein-3 (IGFBP-3), a modulator of IGF action (2) , all decrease with age (3) . Most of the IGF-I in the serum is believed to be generated from the liver, and its concentration depends on the amount of GH secreted, except in certain conditions such as malnutrition, liver dysfunction and GH receptor abnormality (4) . Circulating IGF-I is bound mainly to IGFBP-3, and serum IGFBP-3 level is reported to be positively regulated by GH and/or IGF-I (5-7). Although several lines of evidence have suggested that GH plays an important role in the maintenance of bone mass in adults (3, 8, 9) , it remains unclear whether the GH-IGF-I-IGFBP-3 axis is actually responsible for the age-dependent decrease in bone mass. The recent development of dual-energy X-ray absorptiometry (DXA) has enabled us to analyze body composition in terms of lean body mass (LBM) and fat mass easily and precisely (10) . Our previous study showed that DXA is useful for the analysis of age-and sex-dependent changes in body composition (11) . The present study aimed to examine the age-dependent changes in body composition in postmenopausal Japanese women with special reference to the possible roles of GH, IGF-I and IGFBP-3.
Subjects and methods

Subjects
A total of 161 postmenopausal Japanese women aged 45 to 88 years (mean 62) participated in this study and gave informed consent. The study was approved by the institutional review board of our institution. All the women had been without spontaneous menses for over a year. Serum estradiol was less than 20 pg/ml. No subject had hepatic or renal dysfunction or nutritional derangements that might cause changes in body composition. None were taking drugs known to influence bone metabolism and body composition before the time of the study.
Measurement of body composition
Bone mineral content (BMC), LBM and fat mass were measured by DXA (QDR-2000 Hologic Inc, Boston, MA, USA) using whole-body absorptiometry software and expressed in kg. Percentage BMC, LBM and fat mass were calculated by dividing each absolute value of body composition by total body mass. Percentage trunk fat was calculated by dividing trunk fat mass by total fat mass and was designated %trunk fat. The same operator tested all the women during the study to eliminate operator discrepancies. A strong correlation between body weight and total body mass measured by DXA (r=0.98) was obtained in a preliminary study. Coefficients of variation of measurements of BMC, LBM and fat mass were 0.9, 1.0 and 2.0% respectively.
Biochemical measurements
Since the main daily GH peak occurs in adults during the early nocturnal phase of sleep, urine was collected just after waking in the morning on three days. There is considerable day to day variation; therefore the mean of three GH concentrations divided by creatinine was used as an index of endogenous GH secretion. Urinary GH was measured by a sandwich enzyme immunoassay (12, 13) , and the coefficient of variation defined over the range 3.4-36 ng/l. Intra-assay and interassay variations of this measurement were 6-8 and 9-10% respectively. After overnight fasting, serum was collected. Serum was promptly separated and stored at ¹20 ЊC until assay. Serum IGF-I was measured by RIA after acid-ethanol extraction (14, 15) . Serum IGFBP-3 was also measured by RIA (5). The coefficients of variation for serum IGF-I and IGFBP-3 levels were defined over the range 10-1000 and 0.625-10 ng/ml respectively. Intra-assay and interassay variations of these measurements were 3-4 and 7-8% respectively.
Statistical analysis
Regression analysis was performed using the statistical computer program Abacus Concepts Statview (Abacus Concepts Inc., Berkeley, CA, USA). Simple regression analysis was performed to assess the linear relationship between study parameters. Pearson's correlation coefficients were calculated. P<0.05 was considered statistically significant. In some cases, multiple regression analyses were also employed.
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Figure 1 Changes in body composition with age. The percentage of BMC, LBM and FAT were calculated by dividing each absolute value of body composition by total body mass and expressed as %BMC, %LBM and %FAT.
Results
Age-dependent changes in body composition as well as urinary GH level and serum levels of IGF-I and IGFBP-3 Figure 1 shows changes in body composition with age in postmenopausal women. As for bone, BMC as well as %BMC clearly declined with age. On the other hand, although LBM declined to some extent with age, neither %LBM nor fat and %fat significantly changed with age. Figure 2 shows age-dependent decreases in urinary GH levels as well as serum levels of IGF-I and IGFBP-3.
Role of GH, IGF-I and IGFBP-3 in the regulation of body composition
Since urinary GH levels and serum levels of IGF-I and IGFBP-3 as well as BMC and %BMC declined with age, we next examined whether the GH-IGF-I-IGFBP-3 axis was actually involved in age-dependent bone loss. As shown in Fig. 3 , urinary GH and serum levels of IGF-I and IGFBP-3 correlated positively with BMC and %BMC. Multiple regression analyses were also employed to explore further whether there is an age-independent correlation between BMC and the GH-IGF-I-IGFBP-3 axis (Table 1) . Age was indeed a greater predictor of BMC; however, BMC still correlated positively with urinary GH level as well as serum levels of IGF-I and IGFBP-3, even if age was taken into account.
As shown in Fig. 4 , LBM did not correlate with either urinary GH or serum IGFBP-3 levels, but exhibited a weakly positive correlation with serum IGF-I level. This correlation between LBM and serum IGF-I level was also significant, even if age was taken into account (data not shown). Serum levels of IGF-I and IGFBP-3 correlated negatively with %LBM, whereas urinary GH correlated positively with %LBM.
Urinary GH level correlated negatively with fat and %fat (Fig. 5) . In contrast, serum levels of IGF-I and IGFBP-3 correlated positively with fat and %fat. All these correlations were also significant, even if age was taken into account (data not shown). As shown in Fig.  6 , urinary GH level correlated negatively with %trunk fat, but no significant correlation was found between %trunk fat and serum levels of IGF-I or IGFBP-3. 
Discussion
It is well known that normal human aging is associated with characteristic changes in body composition, including decreases in bone mass and LBM and an increase in adiposity, which progress particularly rapidly in mid and late adulthood (1). Hydrodensitometry, skinfold thickness measurement and 40 K spectrometry have been used for analysis of body composition (16) . Previous studies using these methods revealed an
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Figure 3
Relationship between BMC and urinary GH level (expressed as pg/mg creatinine (Creat)) or serum levels of IGF-I and IGFBP-3. %BMC was calculated by dividing BMC by total body mass.
Figure 4
Relationship between LBM and urinary GH level (pg/mg creatinine (Creat)) or serum levels of IGF-I and IGFBP-3. %LBM was calculated by dividing LBM by total body mass.
age-dependent decrease in lean mass and a reciprocal increase in fat mass (17, 18) . The recent development of DXA has enabled us to measure body composition more precisely and easily (11) . The present study using DXA revealed that BMC clearly declined and LBM declined to some extent with age in postmenopausal Japanese women, which is in agreement with our previous data using DXA (11) . The present study also shows that BMC declines more extensively with age than LBM. Since LBM reflects the overall mass of skeletal muscle, skin and visceral organs, our data indicate that women lose bone mass much more rapidly than muscle and organ mass with age. On the other hand, the present and our previous studies (11) reveal that fat mass does not obviously change with age. Our data are compatible with those obtained using dual photon absorptiometry (DPA) reported by Lindsay et al. (19) , although Hassager & Christiansen (20) reported that %fat measured by DPA increased with age in both sexes. Although we could not clarify the reason for these discrepancies, an ethnic difference in fat mass changes with age may exist.
Several lines of evidence have indicated that the measurement of GH levels in morning urine specimens is useful for the diagnosis of GH deficiency, since urinary GH excretion grossly reflects endogenous GH secretion (21, 22) . However, urinary GH excretion is influenced by renal tubular function (23, 24) , and the possibility cannot be ruled out that renal tubular dysfunction may be masked in older subjects, although serum creatinine levels of all women, less than 0.9 mg/dl, are presumed to be normal. Therefore, estimation of urinay GH level as an index of the endogenous rate of GH secretion was restricted to subjects younger than 70. The present study revealed that urinary GH level as well as serum levels of IGF-I and IGFBP-3 declined with age, which is compatible with previous reports (3). The present findings indicate an age-dependent attenuation of the GH-IGF-I-IGFBP-3 axis in postmenopausal women.
In the present study, urinary GH level and serum levels of IGF-I and IGFBP-3 all correlated positively with BMC and %BMC. Moreover, multiple regression analyses revealed age-independent positive correlations between BMC and urinary GH level as well as serum levels of IGF-I and IGFBP-3. The present findings suggest an important role for endogenous GH secretion in the maintenance of bone mass in postmenopausal women and also suggest that age-dependent suppression of the GH-IGF-I-IGFBP-3 axis may be partly involved in the age-dependent bone loss.
In our study, fat and %fat correlated negatively with urinary GH level but positively with serum levels of IGF-I and IGFBP-3. In vitro experiments with adipose tissue slices and isolated adipocytes have revealed a lipolytic action of GH and the presence of somatotropic receptors on the cell membrane as well as an anti-lipolytic effect of IGF-I on GH-induced lipolysis (25) (26) (27) (28) , indicating a direct antagonistic action between GH and IGF-I on the lipolytic activity of adipocytes. Taken together, the present data suggest that GH negatively regulates fat mass not via the IGF-I-IGFBP-3 pathway and that IGF-I-IGFBP-3 positively regulates fat mass independently of GH. Since GH levels and serum levels of IGF-I and IGFBP-3 decrease with age, these counterregulatory Figure 5 Relationship between fat mass and urinary GH level (expressed as pg/mg creatinine (Creat)) or serum levels of IGF-I and IGFBP-3. %FAT was calculated by dividing fat by total body mass.
actions of GH and IGF-I-IGFBP-3 on fat mass may cancel each other out and partly explain why aging does not appear to affect fat mass.
The age-related decrease in GH is reported to be strongly related to the proportion of abdominal body fat (3, 29) . GH administration to both GH-deficient children and adults prompted a redistribution of adipose tissue from the abdomen to the periphery and decreased lipogenesis in abdominal tissue (3, 29) . In the present study, GH levels but not serum levels of IGF-I and IGFBP-3 correlated negatively with %trunk fat. The present findings therefore suggest that the redistribution by GH of abdominal fat tissue is not via the IGF-I-IGFBP-3 pathway but a direct action of GH itself.
It is reported that muscle makes up 50% of LBM in young subjects, whereas half of the muscle mass has disappeared at age 75 because of reductions in both number and size of the myocytes (1, 30) . However, the change in LBM was minimal and less prominent, compared with that in bone mass, although the agedependent decrease in LBM was statistically significant in this study. Since the shrinkage of LBM does not simply reflect atrophy of skeletal muscles but is also influenced by changes in other tissues such as skin and visceral organs, a reduction in muscle mass may be masked by changes in the other components, even if it did indeed decrease. Controversy still exists about whether GH mediates its anabolic action on muscle through IGF-I (31-34). The present study did not clarify this point, because there was a small but statistically significant correlation between LBM and serum IGF-I, but not between LBM and urinary GH. Although we found that %LBM correlated positively with urinary GH and negatively with serum IGF-I and IGFBP-3, these changes would be secondary or the result of the effects on fat mass.
Decreases in bone and muscle mass are characteristic features of normal human aging. These changes are associated with progressive impairment of bone and muscle strength, which increases the risk of falls and bone fractures. GH deficiency causes bone loss and reduction of LBM, and correction of GH deficiency reverses this trend (8, 29) . The present data provide additional evidence about the crucial role of the GH-IGF-I-IGFBP-3 axis in the maintenance of body composition, particularly bone mass, in postmenopausal women. In addition, natural attenuation of GH secretion causes expansion of the intra-abdominal adipose mass, which is known to be closely related to increased risk of arteriosclerosis. Taking all its effects together, GH is important for the physiological regulation and maintenance of body composition as well as metabolic function during adult life.
Subjects enrolled in the present study may not represent the general population. Consequently, assessment of larger numbers of patients from the general population and population studies are necessary to clarify the precise role of the GH-IGF-I-IGFBP-3 axis in the regulation of body composition.
In conclusion, the present study shows age-dependent changes in body composition in postmenopausal Japanese women. GH as well as IGF-I and IGFBP-3 plays an important role in the age-dependent changes in body composition.
Figure 6
Relationship between %trunk fat and urinary GH level (expressed as pg/mg creatinine (Creat)) or serum levels of IGF-I and IGFBP-3. %Trunk fat was calculated by dividing trunk fat mass by total fat mass.
